663 related articles for article (PubMed ID: 15057410)
1. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
[TBL] [Abstract][Full Text] [Related]
2. Control of Clostridium perfringens vaccines using an indirect competitive ELISA for the epsilon toxin component - examination of the assay by a collaborative study.
Rosskopf-Streicher U; Volkers P; Werner E
Pharmeuropa Bio; 2004 Jan; 2003(2):91-6. PubMed ID: 14960265
[TBL] [Abstract][Full Text] [Related]
3. Replacement of the in vivo neutralisation test for efficacy demonstration of tetanus vaccines ad us. vet.
Rosskopf U; Noeske K; Werner E
ALTEX; 2005; 22(3):169-74. PubMed ID: 16186992
[TBL] [Abstract][Full Text] [Related]
4. Modified toxin-binding inhibition (ToBI) test for epsilon antitoxin determination in serum of immunized rabbits.
Sobrinho EM; Cangussu AS; Brandi IV; Sari RS; Almeida AC; Colen F; Quintilio W; Santos HO
Vet Immunol Immunopathol; 2010 Nov; 138(1-2):129-33. PubMed ID: 20709411
[TBL] [Abstract][Full Text] [Related]
5. Development of a flow cytometric bead immunoassay and its assessment as a possible aid to potency evaluation of enterotoxaemia vaccines.
Buys A; Macdonald R; Crafford J; Theron J
J S Afr Vet Assoc; 2014 Mar; 85(1):977. PubMed ID: 24832497
[TBL] [Abstract][Full Text] [Related]
6. Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines.
Hauer PJ; Clough NE
Dev Biol Stand; 1999; 101():85-94. PubMed ID: 10566780
[TBL] [Abstract][Full Text] [Related]
7. Development and prevalidation of two different ELISA systems for the potency testing of Clostridium perfringens beta and epsilon-toxoid containing veterinary vaccines.
Ebert E; Oppling V; Werner E; Cussler K
FEMS Immunol Med Microbiol; 1999 Jul; 24(3):299-311. PubMed ID: 10397315
[TBL] [Abstract][Full Text] [Related]
8. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
Gupta RK; Siber GR
Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
[TBL] [Abstract][Full Text] [Related]
9. Development of a cell culture assay for the quantitative determination of vaccination-induced antibodies in rabbit sera against Clostridium perfringens epsilon toxin and Clostridium novyi alpha toxin.
Borrmann E; Schulze F; Cussler K; Hänel I; Diller R
Vet Microbiol; 2006 Apr; 114(1-2):41-50. PubMed ID: 16361070
[TBL] [Abstract][Full Text] [Related]
10. [The use of the toxin binding inhibition test for potency testing of Clostridium novyi type B alpha toxoid vaccines].
Luick K; Gottschaldt J; Schulze F; Werner E; Erler W; Borrmann E
Dtsch Tierarztl Wochenschr; 2002 Apr; 109(4):178-82. PubMed ID: 11998370
[TBL] [Abstract][Full Text] [Related]
11. Potency against enterotoxemia of a recombinant Clostridium perfringens type D epsilon toxoid in ruminants.
Lobato FC; Lima CG; Assis RA; Pires PS; Silva RO; Salvarani FM; Carmo AO; Contigli C; Kalapothakis E
Vaccine; 2010 Aug; 28(38):6125-7. PubMed ID: 20670910
[TBL] [Abstract][Full Text] [Related]
12. Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for Clostridia antiserum for serological potency testing of veterinary clostridial vaccines.
Lucken R; Daas A; Behr-Gross ME
Dev Biol (Basel); 2002; 111():171-80. PubMed ID: 12678238
[TBL] [Abstract][Full Text] [Related]
13. An in vitro alternative to the mouse neutralisation assay for potency testing of betatoxoid containing Clostridium, perfringens type B and type C vaccines for veterinary use.
Ebert E; Kusch M; Öppling V; Werner E; Cussler K
ALTEX; 1996; 13(2):68-75. PubMed ID: 11178445
[TBL] [Abstract][Full Text] [Related]
14. Production and evaluation of a monoclonal antibody to Clostridium perfringens type D epsilon toxin.
El-Enbaawy MI; Abdalla YA; Hussein AZ; Osman RM; Selim SA
Egypt J Immunol; 2003; 10(1):77-81. PubMed ID: 15719625
[TBL] [Abstract][Full Text] [Related]
15. Naturally acquired antibodies against Clostridium perfringens epsilon toxin in goats.
Veschi JL; Bruzzone OA; Losada-Eaton DM; Dutra IS; Fernandez-Miyakawa ME
Vet Immunol Immunopathol; 2008 Sep; 125(1-2):198-202. PubMed ID: 18538416
[TBL] [Abstract][Full Text] [Related]
16. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
[TBL] [Abstract][Full Text] [Related]
17. Detection of Clostridium perfringens epsilon toxin by ELISA.
Naylor RD; Martin PK; Sharpe RT
Res Vet Sci; 1987 Mar; 42(2):255-6. PubMed ID: 2884704
[TBL] [Abstract][Full Text] [Related]
18. Selection of a Clostridium perfringens type D epsilon toxin producer via dot-blot test.
Gonçalves LA; Lobato ZI; Silva RO; Salvarani FM; Pires PS; Assis RA; Lobato FC
Arch Microbiol; 2009 Nov; 191(11):847-51. PubMed ID: 19779698
[TBL] [Abstract][Full Text] [Related]
19. Serological assays as alternatives to the Ph Eur challenge test for batch release of tetanus vaccines for human use.
Winsnes R; Hendriksen C; Sesardic D; Akkermans A; Daas A
Dev Biol Stand; 1999; 101():277-88. PubMed ID: 10566802
[TBL] [Abstract][Full Text] [Related]
20. Vaccination schedules to raise antibody concentrations against epsilon-toxin of Clostridium perfringens in ewes and their triplet lambs.
de la Rosa C; Hogue DE; Thonney ML
J Anim Sci; 1997 Sep; 75(9):2328-34. PubMed ID: 9303449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
